Burning mouth syndrome: a review of therapeutic approach
ReviewHumans
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- What treats burning mouth syndrome: a survey of pharmacological options, including ultramicronised palmitoylethanolamide, and non-pharmacological approaches, drawn from PubMed/MEDLINE, Cochrane Library and Web of Science
What the authors reported
The author lists pharmacological treatments used for burning mouth syndrome, including capsaicin, clonazepam, low-dose aripiprazole, alpha-lipoic acid, duloxetine, amitriptyline, gabapentin, pregabalin and ultramicronised palmitoylethanolamide, plus non-pharmacological options such as cognitive therapy, laser therapy, acupuncture and rTMS. No treatment is confirmed as a standard.
Limits of this study
A narrative review with no trial numbers or effect sizes given for palmitoylethanolamide. Funding and conflicts not stated in the abstract.
Source
PubMed 34881535 · doi:10.1515/jcim-2021-0434
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.